The DOI matches its Crossref record; 159 of the 164 references it cites were found in a registry or an index.
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
Open accessAbstract
Objective Systemic lupus erythematosus (SLE) is a complex disease with variable presentations, course and prognosis. We sought to develop evidence-based recommendations addressing the major issues in the management of SLE. Methods The EULAR Task Force on SLE comprised 19 specialists and a clinical epidemiologist. Key questions for the management of SLE were compiled using the Delphi technique. A systematic search of PubMed and Cochrane Library Reports was performed using McMaster/Hedges clinical queries' strategies for questions related to the diagnosis, prognosis, monitoring and treatment of SLE. For neuropsychiatric, pregnancy and antiphospholipid syndrome questions, the search was conducted using an array of relevant terms. Evidence was categorised based on sample size and type of design, and the categories of available evidence were identified for each recommendation. The strength of recommendation was assessed based on the category of available evidence, and agreement on the statements was measured across the 19 specialists. Results Twelve questions were generated regarding the prognosis, diagnosis, monitoring and treatment of SLE, including neuropsychiatric SLE, pregnancy, the antiphospholipid syndrome and lupus nephritis. The evidence to support each proposition was evaluated and scored. After discussion and votes, the final recommendations were presented using brief statements. The average agreement among experts was 8.8 out of 10. Conclusion Recommendations for the management of SLE were developed using an evidence-based approach followed by expert consensus with high level of agreement among the experts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, anti-dsDNA testing is an essential part of the diagnosis, classification, and management of SLE (2,3,(11)(12)(13)”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [11]
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citationWolfe, R. A., Ashby, V. B., Milford, E. L., OJO, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,370
Tsokos, G. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Competing interests: none declared.
Hirsch, L. (2006) · Cited by 1,396
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Mejía, J. C., Aydintug, A. O., Chwalinska-Sadowska, H., de Ramón, E., et al. (2003) · Medicine · doi:10.1097/01.md.0000091181.93122.55 · Cited by 1,377
Austin, H. A., Klippel, J. H., Balow, J. E., LeRICHE, N. G. H., Steinberg, A. D., Plötz, P. H., & Decker, J. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141004 · Cited by 1,189
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Petri, M., Kim, M., KALUNIAN, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M. D., Merrill, J. T., Belmont, M. H., Askanase, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051135 · Cited by 1,166
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C. B., Kim, M., Buyon, J. P., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,122
Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis
Chan, T. M., Li, F., Tang, C. S.-O., Wong, R. W. S., Fang, G. X., Ji, Y., Lau, C. S., Wong, A. K., Tong, M. K. L., Chan, K. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431604 · Cited by 949
Flagged first, then by citations
5 of the 164 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 2001, AGREE Instrument., The AGREE collaboration
Cited by
Sorted by citations
Items 101–200 of 760
Antimalarial-induced cardiomyopathy: a systematic review of the literature
Tselios, K., Deeb, M., Gladman, D. D., Harvey, P., & Urowitz, M. B. (2017) · Lupus · doi:10.1177/0961203317734922 · Cited by 78
Anghel, L. A., Farcas, A. M., & Oprean, R. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s165101 · Cited by 80
Jesús, D., Larosa, M., Henriques, C., Matos, A. C., Zen, M., Tomé, P., Alves, V. N. N., Costa, N., Guern, V. L., Iaccarino, L., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220363 · Cited by 80
Contemporary treatment of systemic lupus erythematosus: an update for clinicians
Amissah-Arthur, M., & Gordon, C. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310380100 · Cited by 76
Abatacept therapy and safety management
Pham, T., Bachelez, H., Berthelot, J., Blacher, J., Claudepierre, P., Constantin, A., Fautrel, B., Gaujoux-Viala, C., Goëb, V., Gossec, L., et al. (2012) · Joint Bone Spine · doi:10.1016/s1297-319x(12)70011-8 · Cited by 76
Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years
Aguiar, R., Araújo, C., Martins‐Coelho, G., & Isenberg, D. A. (2016) · Arthritis Care & Research · doi:10.1002/acr.22921 · Cited by 75
Temporal relationships between systemic lupus erythematosus and comorbidities
Kuo, C., Chou, I., Rees, F., Grainge, M. J., Lanyon, P., Davenport, G., Mallen, C. D., Chung, T., Chen, J., Zhang, W., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/key335 · Cited by 75
Floris, A., Piga, M., Cauli, A., & Mathieu, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.019 · Cited by 74
de Amorim, L. C. D., Maia, F. M., & Rodrigues, C. E. M. (2017) · Lupus · doi:10.1177/0961203316688784 · Cited by 71
Gergianaki, I., & Bertsias, G. K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00161 · Cited by 74
Garg, S., Unnithan, R., Hansen, K. E., Costedoat-Chalumeau, N., & Bartels, C. M. (2020) · Arthritis Care & Research · doi:10.1002/acr.24155 · Cited by 71
Rúa‐Figueroa, Í., López-Longo, F. J., Alén, J. C., Galindo-Izquierdo, M., Loza, E., de Yébenes, M. J. G., & Pego‐Reigosa, J. M. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2013.04.013 · Cited by 72
Systemic lupus erythematosus: pathogenesis and targeted therapy
Su, X., Yu, H. M., Lei, Q., Chen, X., Tong, Y., Zhang, Z., Yang, W., Guo, Y., & Lin, L. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00217-8 · Cited by 84
New directions in the treatment of systemic lupus erythematosus
KALUNIAN, K. C., & Joan, T. M. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902929104 · Cited by 69
Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled Trial
Petri, M., Naqibuddin, M., Sampedro, M., Omdal, R., & Carson, K. A. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.02.005 · Cited by 70
Dima, A., Jurcuț, C., & Băicuş, C. (2018) · Rheumatology International · doi:10.1007/s00296-018-4059-4 · Cited by 70
Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management
Nikolopoulos, D., Fanouriakis, A., & Boumpas, D. T. (2019) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.30.1.7 · Cited by 71
Jonsdottir, T., Zickert, A., Sundelin, B., Henriksson, E. W., van Vollenhoven, R., & Gunnarsson, I. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/kes348 · Cited by 67
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
The OFSEP Group, Cobo‐Calvo, Á., The REEM Group, Sepúlveda, M., d’Indy, H., Armangué, T., Ruiz, A., Maillart, É., Papeix, C., Audoin, B., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-018-9160-9 · Cited by 67
Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage
MOREUIL, C. D., Alavi, Z., & Pasquier, É. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14131 · Cited by 67
Zhang, M., Wang, Y., Wang, Y., Bai, Y., & Gu, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860794 · Cited by 65
The treatment of anti-phospholipid syndrome: A comprehensive clinical approach
Chighizola, C. B., Andréoli, L., Gerosa, M., Tincani, A., Ruffatti, A., & Meroni, P. L. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.02.003 · Cited by 66
CHOROIDAL THICKNESS IN MULTISYSTEMIC AUTOIMMUNE DISEASES WITHOUT OPHTHALMOLOGIC MANIFESTATIONS
Ferreira, C. S., Beato, J. N., Falcão, M. S., Brandão, E., Falcão‐Reis, F., & Carneiro, Â. M. (2016) · Retina · doi:10.1097/iae.0000000000001193 · Cited by 64
Ruiz‐Irastorza, G., Ruiz-Estevez, B., Lazaro, E., Ruiz‐Arruza, I., Duffau, P., Cascón, M. M., Richez, C., Ugarte, A., & Blanco, P. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102359 · Cited by 62
Costello, R. E., Patel, R., HUMPHREYS, J. H., McBeth, J., & Dixon, W. G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014603 · Cited by 63
Quality of Care for Incident Lupus Nephritis Among Medicaid Beneficiaries in the United States
Yazdany, J., Feldman, C. H., Liu, J., Ward, M. M., Fischer, M. A., & Costenbader, K. H. (2013) · Arthritis Care & Research · doi:10.1002/acr.22182 · Cited by 62
Hollander, M. C., Sage, J. M., Greenler, A. J., Pendl, J. D., Avčin, T., Espada, G., Beresford, M. W., Henrickson, M., Lee, T. Y., Punaro, M., et al. (2013) · Arthritis Care & Research · doi:10.1002/acr.21998 · Cited by 62
Rúa‐Figueroa, Í., Richi, P., López-Longo, F. J., Galindo-Izquierdo, M., Alén, J. C., Olivé, A., Loza, E., Pérez-Vicente, S., Erausquin, C., Tomero, E., et al. (2015) · Medicine · doi:10.1097/md.0000000000000267 · Cited by 60
Fiechtner, J., & Montroy, T. (2014) · Lupus · doi:10.1177/0961203314532562 · Cited by 61
Pagni, F., Galimberti, S., Goffredo, P., Basciu, M., Malachina, S., Pilla, D. M., Galbiati, E., & Ferrario, F. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft272 · Cited by 61
Klumb, E. M., Silva, C. A., Lanna, C. C. D., Sato, E. I., Borba, E. F., Brenol, J. C. T., de Albuquerque, E. M. D. N., Monticielo, O. A., Costallat, L. T. L., Latorre, L. C., et al. (2014) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2014.09.008 · Cited by 61
Mehta, N. N., Dey, A. K., Maddineni, R., Kraus, W. E., & Huffman, K. M. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100120 · Cited by 58
Ben‐Menachem, E. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181e8138e · Cited by 60
Presentation of SLE in UK primary care using the Clinical Practice Research Datalink
Nightingale, A. L., Davidson, J. E., Molta, C. T., Kan, H. J., & McHugh, N. J. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000172 · Cited by 60
Antiphospholipid-Related Chorea
Peluso, S., Antenora, A., Rosa, A. D., Roca, A., Maddaluno, G., Morra, V. B., & Michele, G. D. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00150 · Cited by 58
Boström, C., Elfving, B., Dupre, B. J., Opava, C. H., Lundberg, I. E., & Jansson, E. (2016) · Lupus · doi:10.1177/0961203315622817 · Cited by 60
Patient-reported fatigue and its impact on patients with systemic lupus erythematosus
Sterling, K., Gallop, K., Swinburn, P., Flood, E. M., French, A., Sawah, S. A., Iikuni, N., Naegeli, A. N., & Nixon, A. (2013) · Lupus · doi:10.1177/0961203313511554 · Cited by 58
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
O’Connell, T. F., Bradley, C. J., Abbas, A. E., Williamson, B. D., Rusia, A., Tawney, A. M., Gaines, R., Schott, J., Dmitrienko, A. A., & Haines, D. E. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.07.016 · Cited by 58
Roth, D. A., Thompson, A., Tang, Y., Hammer, A. E., Molta, C. T., & Gordon, D. N. (2015) · Lupus · doi:10.1177/0961203315604909 · Cited by 57
van Vollenhoven, R., Petri, M., Wallace, D. J., Roth, D. A., Molta, C. T., Hammer, A. E., Tang, Y., & Thompson, A. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39682 · Cited by 56
Koelmeyer, R., Nim, H. T., Nikpour, M., Sun, Y. B., Kao, A. H., Guenther, O., Morand, E. F., & Hoi, A. Y.-B. (2020) · Lupus Science & Medicine · doi:10.1136/lupus-2019-000372 · Cited by 56
Gordon, C., Amissah-Arthur, M.-B., Gayed, M., Brown, S., Bruce, I. N., D’Cruz, D. P., Empson, B., Griffiths, B., Jayne, D. R. W., Khamashta, M. A., et al. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex291 · Cited by 55
Little, J., Parker, B., Lunt, M., Hanly, J. G., Urowitz, M. B., Clarke, A. E., Romero‐Díaz, J., Gordon, C., Bae, S., Bernatsky, S., et al. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex444 · Cited by 55
Piga, M., Chessa, E., Peltz, M. T., Floris, A., Mathieu, A., & Cauli, A. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.01.011 · Cited by 53
Saccon, F., Zen, M., Gatto, M., Margiotta, D. P. E., Afeltra, A., Ceccarelli, F., Conti, F., Bortoluzzi, A., Govoni, M., Frontini, G., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217070 · Cited by 52
Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus
Tselios, K., Gladman, D. D., Su, J., & Urowitz, M. B. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11267 · Cited by 54
Morita, S., Takahashi, T., Yoshida, Y., & Yokota, N. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000261 · Cited by 52
Survival in systemic lupus erythematosus, 1995–2010. A prospective study in a Danish community
Voss, A., Laustrup, H., Hjelmborg, J., & Junker, P. (2013) · Lupus · doi:10.1177/0961203313498796 · Cited by 52
Physical activity in patients with systemic lupus erythematosus and matched controls
Eriksson, K., Svenungsson, E., Karreskog, H., Gunnarsson, I., Gustafsson, J. T., Möller, S., Pettersson, S., & Boström, C. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2011.624117 · Cited by 52
Zambrano, Y. C. Z., Ramos, J. D. G., Vargas, N. E. P., Ramirez, D. C., Ramírez-Rodríguez, S. M., Vargas, C., & Bello, Á. H. I. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.03.027 · Cited by 51
Zhan, Z., Yang, Y., Zhan, Y., Chen, D., Liang, L., & Yang, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176457 · Cited by 50
Immune Profiling and Precision Medicine in Systemic Lupus Erythematosus
Nagafuchi, Y., Shoda, H., & Fujio, K. (2019) · Cells · doi:10.3390/cells8020140 · Cited by 49
Fischer‐Betz, R., Chehab, G., Sander, O., Vordenbäumen, S., Voiculescu, A., Brinks, R., & Schneider, M. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120537 · Cited by 49
Reddy, P. S., Legault, H. M., Sypek, J. P., Collins, M. J., Goad, E., Goldman, S. J., Liu, W., Murray, S., Dorner, A. J., & O’Toole, M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2541 · Cited by 50
Bortoluzzi, A., Fanouriakis, A., Appenzeller, S., Costallat, L. T. L., Scirè, C. A., Murphy, E., Bertsias, G. K., Hanly, J. G., & Govoni, M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015546 · Cited by 49
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
Gordon, C., Bertsias, G. K., Ioannidis, J. P. A., Boletis, J. N., Bombardieri, S., Cervera, R., Dostál, C., Font, J., Gilboe, I.-M., Houssiau, F., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083022 · Cited by 49
Antiphospholipid syndrome: state of the art on clinical practice guidelines
Limper, M., Scirè, C. A., Talarico, R., Amoura, Z., Avčin, T., Basile, M., Burmester, G. R., Carli, L., Cervera, R., Costedoat-Chalumeau, N., et al. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000785 · Cited by 50
Obesity and Cytokines in Childhood-Onset Systemic Lupus Erythematosus
Sinicato, N. A., Postal, M., Peres, F. A., Peliçari, K. D. O., Marini, R., Santos, A. O., Ramos, C. D., & Appenzeller, S. (2014) · Journal of Immunology Research · doi:10.1155/2014/162047 · Cited by 49
The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies
Wang, Y., Xiao, S., Xia, Y., & Wang, H. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08898-7 · Cited by 47
Gasparyan, A. Y., Ayvazyan, L., Akazhanov, N. A., & Kitas, G. D. (2013) · Croatian Medical Journal · doi:10.3325/cmj.2013.54.600 · Cited by 47
Improving care delivery and outcomes in pediatric rheumatic diseases
Harris, J. G., Bingham, C. A., & Morgan, E. M. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000257 · Cited by 47
Risks and benefits of corticosteroids in arthritic diseases in the clinic
Πέττα, Ι., Peene, I., Elewaut, D. S., Vereecke, L., & Bosscher, K. D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.009 · Cited by 51
Wallace, D. J., Dörner, T., Pisetsky, D. S., Sánchez‐Guerrero, J., Patel, A. C., Parsons‐Rich, D., Bolay, C. L., Drouin, E. E., Kao, A. H., Guehring, H., et al. (2022) · ACR Open Rheumatology · doi:10.1002/acr2.11511 · Cited by 46
Traditional Chinese medicine therapy improves the survival of systemic lupus erythematosus patients
Ma, Y.-C., Lin, C., Li, C.-I., Chiang, J., Li, T., & Lin, J. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.09.006 · Cited by 45
Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence
Ramos‐Casals, M., Díaz‐Lagares, C., Cárdenas, M. J. S., Brito‐Zerón, P., Cuadrado, M. J., Sanna, G., Bertolaccini, M. L., & Khamashta, M. A. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8205-3 · Cited by 46
Gatto, M., Saccon, F., Andréoli, L., Bartoloni, E., Benvenuti, F., Bortoluzzi, A., Bozzolo, E. P., Brunetta, E., Canti, V., Cardinaletti, P., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102729 · Cited by 45
Measuring outcomes in systemic lupus erythematosus clinical trials
Strand, V., & Chu, A. D. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.38 · Cited by 45
Zuily, S., Regnault, V., Guillemin, F., Kaminsky, P., Rat, A., Lecompte, T., & Wahl, D. G. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.04.012 · Cited by 44
Lupus nephritis and pregnancy in the 21st century
Day, C., Lipkin, G. W., & Savage, C. O. S. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn651 · Cited by 44
Abatacept for the treatment of systemic lupus erythematosus
Pimentel-Quiroz, V. R., Ugarte-Gil, M. F., & Alarcón, G. S. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1154943 · Cited by 44
Aerobic and resistance exercise in systemic sclerosis: State of the art
de Oliveira, N. C., Portes, L. A., Pettersson, H., Alexanderson, H., & Boström, C. (2017) · Musculoskeletal Care · doi:10.1002/msc.1185 · Cited by 44
Uric acid and kidney damage in systemic lupus erythematosus
dos Santos, M., Veronese, F. V., & Moresco, R. N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.034 · Cited by 45
Iudici, M., Fasano, S., Falcone, L. G., Pantano, I., MONTAGNA, G. L., Migliaresi, S., & Valentini, G. (2016) · Rheumatology · doi:10.1093/rheumatology/kew231 · Cited by 46
Optimizing clinical monitoring of central nervous system involvement in SLE
Castellino, G., Govoni, M., Giacuzzo, S., & Trotta, F. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.11.022 · Cited by 43
Tselios, K., Koumaras, C., Urowitz, M. B., & Gladman, D. D. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.07.007 · Cited by 43
Pain and systemic lupus erythematosus
Franco, M. D., Guzzo, M. P., Spinelli, F. R., Atzeni, F., Sarzi‐Puttini, P., Conti, F., & Iannuccelli, C. (2014) · Reumatismo · doi:10.4081/reumatismo.2014.762 · Cited by 43
Central Nervous System Manifestations of Antiphospholipid Syndrome
Graf, J. D. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.06.004 · Cited by 44
Trentin, F., Gatto, M., Zen, M., Larosa, M., Nalotto, L., Saccon, F., Zanatta, E., Iaccarino, L., & Doria, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8675-2 · Cited by 43
Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review
Choo, H. M. C., Cher, W. Q., Kwan, Y. H., & Fong, W. W. S. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0055-y · Cited by 43
Greco, R., Alexander, T., Burman, J., Papa, N. D., de Vries‐Bouwstra, J., Farge, D., Henes, J. C., Kazmi, M. A., Киргизов, К. И., Muraro, P. A., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01326-6 · Cited by 44
Assessment of disease activity and quality of life in systemic lupus erythematosus – New aspects
Yee, C., McElhone, K., Teh, L., & Gordon, C. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.01.007 · Cited by 42
Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care
Choi, M. Y., Barber, M. R. W., Barber, C. E. H., Clarke, A. E., & Fritzler, M. J. (2016) · Lupus · doi:10.1177/0961203316640367 · Cited by 43
Teng, Y. K. O., Bredewold, O. W., Rabelink, T. J., Huizinga, T. W. J., Eikenboom, J. C. J., Limper, M., Fritsch-Stork, R. D. E., Bloemenkamp, K. W. M., & Sueters, M. (2017) · Rheumatology · doi:10.1093/rheumatology/kex374 · Cited by 42
Morel, N., Bonjour, M., Guern, V. L., Jeunne, C. L., Mouthon, L., Pietté, J. C., & Costedoat-Chalumeau, N. (2015) · Lupus · doi:10.1177/0961203315593169 · Cited by 42
Update on the management of lupus nephritis: let the treatment fit the patient
Bertsias, G. K., & Boumpas, D. T. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0896 · Cited by 42
Petri, M., Bechtel, B., Dennis, G. J., Shah, M. B., McLaughlin, T. P., Kan, H., & Molta, C. T. (2014) · Lupus · doi:10.1177/0961203314532699 · Cited by 42
Gracia-Tello, B., Ezeonyeji, A. N., & Isenberg, D. A. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000182 · Cited by 42
Nikpour, M., Bridge, J. A., & Richter, S. A. M. (2014) · Internal Medicine Journal · doi:10.1111/imj.12568 · Cited by 41
Periodontal findings in systemic lupus erythematosus patients and healthy controls
Almutairi, K., Al‐Zahrani, M. S., Bahlas, S. M., Kayal, R. A., & Zawawi, K. H. (2015) · Saudi Medical Journal · doi:10.15537/smj.2015.4.10746 · Cited by 41
Ngamjanyaporn, P., McCarthy, E. M., Sergeant, J. C., Reynolds, J. A., Skeoch, S., Parker, B., & Bruce, I. N. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000173 · Cited by 41
Lupus nephritis and B-cell targeting therapy
Cassia, M. A., Alberici, F., Gallieni, M. A., & Jayne, D. R. W. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1366855 · Cited by 41
Jorge, A. M., Melles, R. B., Zhang, Y., Lu, N., Rai, S. K., YOUNG, L. H. Y., Costenbader, K. H., Ramsey‐Goldman, R., Lim, S. S., Esdaile, J. M., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1634-8 · Cited by 41
Kubo, S., Nakayamada, S., & Tanaka, Y. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1608821 · Cited by 42
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
Belizna, C. C., Meroni, P. L., Shoenfeld, Y., Devreese, K. M. J., Alijotas‐Reig, J., Esteve‐Valverde, E., Chighizola, C. B., Pregnolato, F., Cohen, H., Fassot, C., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102525 · Cited by 41
Gerde, M., Ibarra, E. E. M., Kenzie, R. M., Suarez, C. F., Heer, C., Álvarez, R., Iglesias, M., Balparda, J., Beruti, E., & Rubinstein, F. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.08.004 · Cited by 41
Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies
Mecacci, F., Bianchi, B., Pieralli, A., Mangani, B., Moretti, A., Cioni, R. M., Giorgi, L., Mello, G., & Matucci‐Cerinic, M. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken458 · Cited by 41
The clinical and laboratory manifestations of systemic lupus erythematosus
Klyukvina, N. G., & Nasonov, E. L. (2012) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2012-761 · Cited by 41
Stummvoll, G. H., Schmaldienst, S., Smolen, J. S., Derfler, K., & Biesenbach, P. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr239 · Cited by 40
Parodis, I., Johansson, P., Gómez, A., Soukka, S., Emamikia, S., & Chatzidionysiou, K. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez191 · Cited by 40
Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis
Frieri, M., Heuser, W., & Bliss, J. W. (2015) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.155482 · Cited by 40
Metadata
- Authors
- Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., Isenberg, D., Kallenberg, C. G. M., Khamashta, M., Piette, J. C., Schneider, M., Smolen, J., Sturfelt, G., Tincani, A., van Vollenhoven, R., Gordon, C., & Boumpas, D. T.
- Affiliations
- University of Crete (GR)
- University of Ioannina (GR)
- Laiko General Hospital of Athens (GR)
- University of Pisa (IT)
- Hospital Clínic de Barcelona (ES)
- Oslo University Hospital (NO)
- Cliniques Universitaires Saint-Luc (BE)
- Leiden University Medical Center (NL)
- University College Hospital (GB)
- University Medical Center Groningen (NL)
- St Thomas' Hospital (GB)
- Heinrich Heine University Düsseldorf (DE)
- Medical University of Vienna (AT)
- Lund University (SE)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- University of Birmingham (GB)
- Corresponding author
- Boumpas, D T
- ORCID
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 67
- Issue
- 2
- Pages
- 195-205
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2157038471
- Cited by
- 762
- References
- 164
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 19 · 2023: 26 · 2022: 19 · 2021: 58 · 2020: 56 · 2019: 53 · 2018: 70 · 2017: 62 · 2016: 47 · 2015: 53 · 2014: 43 · 2013: 53 · 2012: 46
- FWCI
- 18.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of the Rheumatic Diseases (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- University of Crete
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- systemic lupus erythematosus, clinical management, diagnosis, prognosis, disease surveillance, treatment, neuropsychiatric lupus, pregnancy, antiphospholipid syndrome, lupus nephritis, evidence-based recommendations, expert consensus
- MeSH terms
- Female, Humans, Lupus Erythematosus, Systemic, Lupus Nephritis, Male, Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
